| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |